Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer (Q45106840)

From Wikidata
Jump to navigation Jump to search
scientific article published on 23 March 2009
edit
Language Label Description Also known as
English
Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer
scientific article published on 23 March 2009

    Statements

    Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer (English)
    Eric Van Cutsem
    Walter L Vervenne
    Jaafar Bennouna
    Yves Humblet
    Sharlene Gill
    Jean-Luc Van Laethem
    Chris Verslype
    Werner Scheithauer
    Aijing Shang
    Jan Cosaert
    Malcolm J Moore
    23 March 2009
    2231-2237

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit